Nvelop Therapeutics

Nvelop Therapeutics is a biotechnology company focused on developing the next generation of genetic medicines. They address the limitations of current delivery technologies by engineering programmable, non-viral vehicles for in vivo delivery of therapeutic cargo. Nvelop's platforms are based on two validated approaches developed at the Broad Institute of MIT and Harvard and Massachusetts General Hospital. These platforms are designed to achieve high efficiency and cell-specificity while delivering a broad range of therapeutic cargoes, including ribonucleoproteins.

Nvelop is founded by gene editing pioneers David Liu and Keith Joung, and is backed by top life science investors. Their mission is to transform delivery for a broad range of genetic medicines and modalities in order to treat many previously undruggable diseases. The company has assembled a seasoned team of scientists, operators, and innovators with decades of expertise in the field. Nvelop is committed to building a culture of curiosity, trust, and mutual respect, where they are invested in each employee's growth and development.

Nvelop Therapeutics is a biotechnology company focused on developing the next generation of genetic medicines. They aim to overcome the limitations of current delivery technologies by engineering programmable, non-viral vehicles for the in vivo delivery of therapeutic cargo. This approach has the potential to enable highly efficient and cell-specific delivery of a broad set of therapeutic cargoes, expanding the reach of precision medicines to previously undruggable diseases and ultimately changing the lives of patients.

Nvelop Therapeutics fosters a culture of collaboration, curiosity, and mutual respect. They believe in the power of teamwork to advance science, and are dedicated to supporting employee growth. This culture encourages open communication, creative problem-solving, and a shared passion for pioneering a new era of targeted genetic medicines.

Nvelop Therapeutics emphasizes a culture of curiosity, trust, and mutual respect, fostering an environment where each employee's growth is valued. They believe that great science, particularly in the pursuit of life-changing therapies, is only possible when a diverse and inclusive workplace allows everyone to contribute their best. This commitment to diversity, equity, and inclusion is reflected in their leadership team, which boasts a range of backgrounds and expertise, and their focus on creating a supportive environment where all employees feel respected and empowered.